Hennion & Walsh Asset Management, Inc. Incyte Corp Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.15 Billion
- Q1 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Incyte Corp stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 34,933 shares of INCY stock, worth $2.07 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
34,933
Previous 35,708
2.17%
Holding current value
$2.07 Million
Previous $2.47 Million
14.23%
% of portfolio
0.1%
Previous 0.12%
Shares
15 transactions
Others Institutions Holding INCY
# of Institutions
713Shares Held
189MCall Options Held
909KPut Options Held
489K-
Baker Bros. Advisors LP New York, NY30.7MShares$1.82 Billion23.54% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.26 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.6MShares$1.16 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.9MShares$884 Million0.64% of portfolio
-
State Street Corp Boston, MA10MShares$594 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $13.2B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...